CELLO™, Balloon Guide Catheter 1610590Recalls & reported problems
Fuji Systems Corporation · The CELLO Balloon Guide Catheter is indicated for use in facilitating the insertion and guidance of intravascular catheters into a selected blood vessel in the peripheral and neuro vasculature systems. The balloon provides temporary vascular occlusion during these and other angiographic procedures. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 04544050120746), received between Feb 16, 2023 and Apr 28, 2026 — classified as 1 death, 1 injury, 4 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Burst Container or Vessel2
- Leak/Splash2
- Material Deformation1
- Physical Resistance/Sticking1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- Intracranial Hemorrhage2
- Rupture1
- Stroke/CVA1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 28, 2026Leak/Splash
MEDTRONIC RECEIVED A REPORT THAT A CELLO HAD A CATHETER LEAK. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF A CAROTID ARTERY EMBOLIZATION PROCEDURE. IT WAS NOTED THE PATIENT'S VESSEL TORTUOSITY WAS NORMAL. IT WAS REPORTED THAT THE PHYSICIAN WAS PERFORMING A CAROTID ARTERY EMBOLIZATION PROCEDURE AND INTENDED TO USE CELLO (REF: (B)(4), LOT: 5300224). DURING PRE-USE TESTING, IT WAS FOUND THAT THE BALLOON COULD NOT BE INFLATED, AND LEAKAGE WAS OBSERVED AT THE DISTAL END. THE DEVICE WAS NOT USED FOR ANY BALLOON-RELATED OPERATION, AND NO REPLACEMENT DEVICE WAS USED. THE PROCEDURE WAS COMPLETED SUCCESSFULLY, AND THE PATIENT EXPERIENCED NO ADVERSE EFFECTS. THE CATHETER FLUSHED AND WAS INSPECTED PRIOR TO USE AND THE LEAK WAS OBSERVED DURING PREPARATION. ALL DEVICES WERE PREPARED AS INDICATED IN THE IFU. NO PATIENT COMPLICATIONS WERE ASSOCIATED WITH THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25016469 ↗MalfunctionJan 30, 2025Material Deformation; Physical Resistance/Sticking; Material Deformation; Physical Resistance/Sticking
ADDITIONAL INFORMATION WAS RECEIVED STATING THAT THE CAUSE OF THE RESISTANCE WAS NOT DETERMINED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21275128 ↗MalfunctionJul 23, 2024Burst Container or Vessel; Burst Container or Vessel
MEDTRONIC RECEIVED A REPORT THAT A CELLO BALLOON GUIDE CATHETER ENCOUNTERED AN ISSUE WHERE THE BALLOON TORE OFF. IT WAS THOUGHT TO HAVE BEEN DUE TO CALCIFICATION OF THE VEINS. THE REPORTED DEVICE AND ACCESSORY DEVICES WERE PREPARED AS INDICATED IN THE INSTRUCTION FOR USE (IFU). THE CATHETER WAS FLUSHED AS INDICATED IN THE IFU. THERE WERE NO PATIENT SYMPTOMS OR COMPLICATIONS ASSOCIATED WITH THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19809141 ↗MalfunctionFeb 29, 2024Burst Container or Vessel; Leak/Splash; Burst Container or Vessel; Leak/Splash
MEDTRONIC RECEIVED A REPORT THAT THE OPERATOR FLUSHED THE CATHETER AND ALL THE ACCESSORY DEVICES AS PER INSTRUCTIONS FOR USE (IFU) AND PLACED CELLO 9F AT THE COMMON CAROTID ARTERY (CCA) WITH THE HELP OF DILATOR AND 0.35 WIRE. AFTER SOME TIME, THE OPERATOR NOTICED THAT SALINE WAS LEAKING AT THE HUB OF THE CELLO. THERE WAS NO FORCE APPLIED WHILE CONNECTING THE Y CONNECTOR OR SYRINGE TO THE CATHETER HUB. THE CATHETER WAS INSPECTED OR TESTED PRIOR TO USE. THE LEAD WAS OBSERVED DURING USE. THE OPERATOR DECIDED TO WITHDRAW THE CELLO AND PUT A 7F LONG SHEATH, THEN THROUGH THE LONG SHEATH HE HAD COMPLETED MECHANICAL THROMBECTOMY (MT) WITH ALL OTHER DEVICES AND FINISHED THE CASE. NO PATIENT SYMPTOMS OR FURTHER COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF ACUTE ISCHEMIC STROKE. IT WAS NOTED THE PATIENT'S VESSEL TORTUOSITY WAS SEVERE. THE ACCESS VESSEL WAS THE LEFT INTERNAL CAROTID ARTERY (ICA) WITH A DIAMETER OF 5.1MM. ANCILLARY DEVICES INCLUDE A SHORT SHEATH, AND ACE 68 GUIDE CATHETER.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18807216 ↗DeathFeb 28, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDTRONIC RECEIVED A REPORT THAT THE PATIENT EXPERIENCED HEMORRHAGIC TRANSFORMATION OF A CEREBRAL INFARCTION FOLLOWING A PROCEDURE INVOLVING A REACT 68 CATHETER, CELLO 9F BALLOON CATHETER, AND SOLITAIRE STENT RETRIEVER. NO FURTHER TREATMENT OR HOSPITALIZATION WAS REQUIRED, AND THE EVENT RECOVERED/RESOLVED ON (B)(6) 2022. THE EVENT WAS NOT A NEW OR RECURRENT STROKE, AND WAS NOT THE RESULT OF A DEVICE DEFICIENCY. THE PATIENT'S MRS SCORE WAS 3, AND THEIR NIHSS SCORE WAS 20. THE SITE ASSESSED THE EVENT AS CAUSED BY THE DISEASE UNDER STUDY, AND NOT RELATED TO THE DEVICE, THE PROCEDURE, OR AN UNDERLYING CONDITION. THE SPONSOR ASSESSED THE EVENT AS POSSIBLY RELATED TO THE PROCEDURE. THE PATIENT WAS UNDERGOING TREATMENT FOR 3 CLOTS. THE FIRST WAS LOCATED IN THE LEFT INTERNAL CAROTID ARTERY BELOW THE CAROTID T, THE SECOND IN THE M1 SEGMENT OF THE LEFT MIDDLE CEREBRAL ARTERY (MCA), AND THE THIRD LOCATED IN THE M2 SEGMENT OF THE LEFT MCA. THE PATIENT'S PRE-PROCEDURE MTICI SCORE WAS 0, AND POST-PROCEDURE IT WAS 2C. ADDITIONAL INFORMATION RECEIVED REPORTED THE HEMORRHAGIC TRANSFORMATION OF THE STROKE PATIENT INDEX STROKE ULTIMATELY HAD A FATAL OUTCOME. THE PATIENT HAD UNDERGONE A THROMBECTOMY P
Patient problems: Intracranial Hemorrhage
MAUDE report 16454670 ↗InjuryFeb 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ADDITIONAL INFORMATION RECEIVED REPORTED THAT CEC ADJUDICATED THIS EVENT AS CAUSAL TO THE STUDY PROCEDURE.
Patient problems: Intracranial Hemorrhage; Rupture; Stroke/CVA
MAUDE report 16390726 ↗
Other Catheter, Percutaneous devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page